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Abstract
Recently, the network paradigm, an application of graph theory to biology, has pro-
ven to be a powerful approach to gaining insights into biological complexity, and
has catalyzed the advancement of systems biology. In this perspective and focusing
on the immune system, we propose here a more comprehensive view to go beyond
the concept of network. We start from the concept of degeneracy, one of the most
prominent characteristic of biological complexity, defined as the ability of structurally
different elements to perform the same function, and we show that degeneracy is
highly intertwined with another recently-proposed organizational principle, i.e. ‘bow
tie architecture’. The simultaneous consideration of concepts such as degeneracy,
bow tie architecture and network results in a powerful new interpretative tool that
takes into account the constructive role of noise (stochastic fluctuations) and is able
to grasp the major characteristics of biological complexity, i.e. the capacity to turn an
apparently chaotic and highly dynamic set of signals into functional information.
Background - the complexity of the immune system
The vertebrate immune system (IS) is the result of a long evolutionary history and has
a fundamental role in host defence against bacteria, viruses and parasites. It comprises
a variety of proteins and other molecules, cell types and organs, which interact inten-
sely and communicate in a complex and dynamic network of signals. The IS, like the
nervous system, shows features of a cognitive system: it is capable of learning and
memory, resulting in adaptive behaviour. Indeed, the IS creates an ‘immunological
memory’ of previous information (primary response to a specific pathogen) and adapts
itself for better recognition if the same pathogen recurs, thus providing an enhanced
and more effective response. This adaptation process is referred to as adaptive immu-
nity or acquired immunity, and makes vaccination a powerful clinical strategy [1]. Not-
withstanding the availability of abundant data, a comprehensive theoretical framework
for the functioning of the IS is still underdeveloped [2].
We will briefly illustrate three major conceptualizations that have been proposed to
grasp the complexity of biological systems, and we will pay particular attention to the
IS as one of the most complex systems in the human body, about which numerous
data and several conceptualizations are already available. We will consider the concept
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of network [3], the functioning principle of degeneracy [4], and the recently-observed
bow tie architecture [5]. Such principles are apparently quite pervasive and widespread
in the organization of biological and non-biological complex systems. Several critical
structures of the IS rely for their functioning on the three above-mentioned principles
to afford evolvability, efficiency and robustness (i.e. non-catastrophic response to per-
turbation/noise) [6]. In order to point out the advantage and heuristic power of this
approach, we will briefly summarize the available data on the IS as a network, and we
will focus on three key immunological structures - the T Cell Receptor, Toll-like
Receptor and the proteasome - to illustrate the usefulness of the concepts of degener-
acy and bow tie architecture. We will finally argue that these concepts should be con-
sidered together under the perspective of a unitary hypothesis.
The network approach
The success of a new paradigm
Central to systems biology, the paradigm of network is also at the cutting edge of the
sciences of complexity (see for example the NetSci conference series on network
science at http://netsci2010.net/). Network analysis provides a powerful tool for
describing complex systems, their components and their interactions in order to iden-
tify their topology, as well as structures and functions emerging from the orchestration
of the whole ensemble of elements. This approach has been successfully applied to the
representation and analysis of various systems in different fields, from social studies [7]
to engineering and technology [8] and life sciences [3,9,10], to cite only a few
examples.
The power of network conceptualization lies in the ability to grasp the characteristics
of generic systems of any type, stable and physically wired (i.e. power grids, telephone/
internet cabling) or dynamic and non-wired (air traffic, social networks, protein inter-
actions). Such interdisciplinary and multi-perspective conceptualization makes it possi-
ble to consider biological systems as a whole, and to subject them to rigorous
mathematical analysis.
Networks and the immune system
Attempts to describe the IS using networks have been pioneered by Jerne [11], and
have led to interesting but controversial results. This approach has recently been reju-
venated and extended by many authors with the aim of formalizing the IS more rigor-
ously [2,12-16] within a systems biology perspective. Network models of the IS based
on coupled non-linear differential equations have been used by several authors [17]
and also applied to specific problems such as immunological memory [18]. This math-
ematical approach to the IS has also led to the proposal of IS-inspired paradigms for
new types of computation algorithms [19].
Despite the above-mentioned power, usefulness and flexibility, the network approach
is limited by inherent difficulties in taking into account the functional diversity of the
elements and the wide (qualitative) variety of their interconnections and links, two fea-
tures that strongly impinge upon the real network dynamics and behaviour of biologi-
cal systems [20]. Indeed, poor characterization of the attributes of nodes and
connections is a major issue in network biology. As an example, while the topological
organization of metabolic networks is satisfactorily understood [21,22], the principles
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that govern their global functionality and their dynamics are not. Flux balance analysis
of metabolism in a given E. coli strain revealed that network use is very unbalanced.
Observations led to the conclusion that most metabolic reactions have low flux rates,
but the overall metabolic activity is ruled by a number of reactions with very high flux
rates. In this scenario, E. coli is able to react to changes in growth conditions by reor-
ganizing the rates of given fluxes mainly within this high-flux backbone [23]. Another
important issue is that network analysis is predominantly static. Multiple time points
and network states can be collected and analyzed in a longitudinal fashion, but this is
not yet a dynamical analysis. A further, in some ways minor, limitation may be the
computational intractability of the analysis of large networks characterized by combi-
natorial properties. To go beyond such limits is a challenge in network theory and sys-
tems biology [3].
While the application of the network paradigm revealed the existence of structural
complexity, many other layers of complexity in the system became apparent at the
same time and evaded clearer comprehension owing to the intrinsic limitations of the
network approach.
Among the principles that have been used to tackle these new levels of functional
and architectural complexity, the degeneracy principle [4] and the bow tie architecture
[5] have been proposed. The general consideration underlying these proposals is that
biological complexity probably cannot be explained by a single concept, even a power-
ful one such as that of network, and that other layers of architectural complexity are
present and should be identified, conceptualized and integrated.
The principle of degeneracy
Degeneracy is a most prominent characteristic of biological complexity
Degeneracy has been defined as the “ability of structurally different elements of a sys-
tem to perform the same function” [4,24-26]. In other words, it refers to a partial func-
tional overlap of elements already capable of non-rigid, flexible and versatile
functionality. Consequently, a system that accounts for degenerate elements is provided
with redundant functionality. Redundancy of function confers robustness, i.e. the abil-
ity to cope with (sometimes unpredictable) variations in an operating environment
with minimal damage, alteration or loss of functionality. In a system composed of
degenerate elements, if one fails, others can take over from it in a sort of vicarious
functionality, and yield the expected output or at least a similar one (e.g. sails and oars
for boat propulsion).
It is important to stress that the classical, engineering concept of redundancy is
opposed to that of degeneracy, and often refers to structural similarity, repetition or
multiplication. Redundancy thus refers to the one-to-one, or one structure-one function
paradigm (e.g. a twin-engine boat). While redundancy in this sense can only support
redundant functioning, degeneracy refers to the many structures-one function paradigm
(the converse form of degeneracy, pluripotentiality, refers to the one function-many
structures paradigm). Indeed, to make redundant use of different structures, they will
be required to adapt and sustain a given function. Hence, redundant functioning of a
system composed of heterogeneous elements requires degeneracy.
Within this perspective, Edelman and Gally [4] provided a list of various examples of
degeneracy at different levels of biological organization: the genetic code, in which
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different nucleotide sequences encode the same polypeptide; the protein folding pro-
cess, where different polypeptides can fold so as to be structurally and functionally
equivalent; metabolism, for which multiple, parallel biosynthetic and catabolic path-
ways exist; immune responses, in which populations of antibodies and other antigen-
recognition molecules are degenerate; connectivity in neural networks, in which there
is enormous degeneracy in local circuitry, long-range connections, and neural
dynamics; and many other very interesting cases.
It is to be emphasized that, as in the examples above, degeneracy is a characteristic
pertaining to the elements of a system, but it impinges strongly upon the system’s
dynamics and functionality. Indeed, the architectural characteristics of a system and
the features of individual components together play indispensable roles in forming the
symbiotic state of the system as a whole and thus its dynamics [27,28].
Another structural advantage of degeneracy, in comparison to redundancy, lies in the
evolvability [4,29] of the degenerate element and of the whole system. This evolution-
ary advantage relies on the characteristic that degenerate structures are functionally
overlapping and versatile, and rearrange their configuration to meet internal or exter-
nal (environmental) changes thanks to their interchangeable task capabilities. In other
words, degenerate systems have a flexibility that makes them capable of yielding
unforeseen functionalities, and may thus show evolutionary advantage. It is noteworthy
that on a longer evolutionary time scale, this functional degeneracy coincides with the
Gouldian concept of “ex-aptation": while an ad-aptation (ad + aptus, “shaped toward a
given fitness or usage”) is a feature built by selection for its current role, an ex-aptation
is a character evolved for other usage (or no usage, “non-aptation”) and only later -
from this original usage (ex) - ‘co-opted’ for its current role [30,31].
Apart from robustness and evolvability, another intrinsic characteristic of degeneracy
is the capacity to integrate different signals. There are examples of biological receptor
systems that exploit this feature masterfully. In the retina of the eye, only three types
of light receptors exist (one relative to each of the three fundamental colours) and they
are degenerate: each is responsive to a wide range of electromagnetic frequencies (i.e.
colours) and not to one precise frequency only. The integration of signals from all the
degenerate receptors allows the eye to perceive an incredibly wide range of colours
[26]. All these characteristics of degeneracy have long been considered fundamentally
important in immunology (see Appendix for a historical perspective).
Degeneracy in immunological structures
From a specific immunological perspective, a dynamics of the type that accounts for
the retinal receptors drives the immune Toll-Like Receptors (TLRs), collectively a sort
of “immunological eye”, to recognize immunogenic peptides and to tune the innate
immune response [13,32,33]. Each single TLR is complementary to the others, and
each is able to detect a different repertoire of conserved microbial molecular patterns,
so that the whole TLR system, constituted in humans by 10 different receptors
[34-36], can collectively sense most if not all microbes.
It is to be noticed that degeneracy in the immunological context was originally
referred to as “the ability of a single antigen to activate many different T lymphocyte
clones” [4]. The T lymphocyte, or T cell, plays a central role in cell-mediated immu-
nity, and is distinguishable by the presence of a special, hypervariable receptor on its
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surface (T cell receptor, TCR), which is structurally different in each cell clone. The
TCR (and its co-receptors) can bind antigenic peptides presented within the groove of
the Major Histocompatibility Complex (MHC) cell surface proteins, expressed by spe-
cial antigen-presenting cells (APCs).
The “specificity” paradigm of the TCR has been a long-lasting concept: it was
believed that each TCR could bind (and consequently initiate a response) one and one
with only a specific ‘cognate’ antigen peptide. Mounting evidence [37] subsequently
showed that a dynamics governed by the one antigen-one antibody rule would not
have been sustainable for an organism in terms of mass, energy and response time.
Today, while it is clear that the TCR maintains exquisite specificity in recognizing and
distinguishing antigens, there are unquestionable proofs of TCR degeneracy as an
inherent feature essential for sensing the whole antigenic peptide universe [38,39]. In
this perspective, TCR degeneracy can be considered an architectural and functional
property that gives rise to an optimized trade-off for reasonably full coverage of the
whole potential set of antigenic epitopes [38].
The bow tie architecture
The “bow tie” architecture (so called for its shape; Figure 1) is a recent concept that
tries to grasp the operational and functional architecture of complex and self-organized
systems, including organisms. In the most general terms, bow tie architectures refer to
ordered and recurrent control system structures that underlie complex technological
or biological networks and are capable of conferring a balance among efficiency,
robustness and evolvability. Conversely, it has been argued that the bow tie structure
shows critical weak points [5], which could explain the concomitant characteristic of
biological systems, i.e. their fragility towards specific evolved agents [13].
Figure 1 Schematic representation of a general bow tie architecture. Input signals conveyed through
the fan in (left) are widely diversified. The capacity to admit this variability confers flexibility and robustness
on the system. Then, in the core, inputs (and information complexity) are ‘compressed’ by relatively rigid
rules and protocols, and processed into basic modular building blocks. In the core, critical decisions about
the sorting and the fate of the system outputs are taken. Finally, again through protocols, a variety of
elaborated output fans out, and the complexity of the original, uncompressed information is restored.
Output ® input feedback loops may also occur.
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A bow tie architecture shows the ability to accept a wide range of inputs (in Figure 1
the left, input wing) and convert them to a reduced set of universal building blocks
(the knot, or core). Here, assembly protocols act on these basic modular building
blocks, eventually restoring and fanning out a wide variety of outputs (the right bow).
It is interesting to note that the bow tie can be interpreted as the combination of two
degenerate systems coupled through a single central element, suggesting that the two
concepts of degeneracy and bow tie share a similar conceptual and architectural
design, i.e. the many-to-one (degeneracy) and one-to-many (pluripotentiality) paradigm
(Figure 2).
This kind of architecture has been observed in the structural organization of organ-
isms throughout the biological scale as well as in technological and dynamical systems
where the management, control and restriction of incoming inputs become central, e.g.
metabolic networks [5,40,41], signalling networks [42], TCR signaling [6], pathways of
oxygen signalling and energy of the hypoxia-inducible factor cascade [43], the Internet
[44], large technological installations (see Figure 3); it also accounts for the dynamics
of socio-political phenomena [45], so it may be considered wide-ranging [5].
In general terms, bow ties seem to have evolved specifically to deal with a highly
fluctuating and “sloppy” environment (represented by the fan in bow) and thus to
organize fluxes of information (or matter) optimally into their overall structure. Indeed,
in biological systems, the metabolic process shows nested bow tie structures [5,40,41].
A large number of different nutrient inputs are catabolized (’fan in’) to produce few
carriers (i.e. ATP, NADH and NADPH) and just 12 precursor metabolites (pyruvate,
fructose 6-phosphate, etc.), which are in turn synthesized into ~70 larger building
blocks (nucleotides, amino acids, fatty acids and sugars). The building blocks then fan
out into the assembly of larger macromolecules following general-purpose polymerase
processing [5,40]. Thus, in metabolic networks, the core of the bow tie seems to com-
prise a densely connected, small-world network, which is resistant to single component
failure.
The efficacy, success and observed universality of such architecture rely on its func-
tional organization. Bow ties are able to ensure a virtually unlimited scalability, thanks
to the ability to accept an incredibly high number of different inputs and, at the same
Figure 2 Degeneracy, pluripotentiality and bow tie. The concept of bow tie integrates the concepts of
degeneracy and pluripotentiality: figuratively, a bow tie structure (many-few-many) (1c) appears from the
overlapping of degeneracy (many-to-one) (1a) and pluripotentiality (one-to-many) (1b).
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time, to guarantee robustness and evolvability. Indeed, building blocks are modular
(functionally independent) and can be recombined and reused through universal proto-
cols to meet the demands of a rapidly changing environment. The core of the modular
‘common currencies’ facilitates system control, dampening the effects of noisy context
and thus reducing fluctuations and disturbances.
Conversely, the same efficient architecture may be prone and vulnerable to fragilities
due to specific changes, perturbations, and focused attacks directed against the core set
of building blocks and protocols. If a hijacking process can take control over a protocol
or other elements in the core, the whole system can collapse under the breakdown of
its key regulatory mechanisms, or can be forced to ‘execute’ processes harmful for the
system itself.
Results and discussion - towards an integrative perspective
TLR integrated functioning
Bow tie architectures have been observed in the functional structure of some key com-
ponents of the innate immune response, such as the human TLRs system, and of the
adaptive immune system, such as the TCR.
Even if microbial stimulatory molecules, sensed by the TLRs, constitute a very com-
plex stereochemical set (in number and quality), and although the response involves
many genes, signals mediated by the TLR system cross a funnel of diminished or com-
pressed complexity [32], as in a bow tie core. Indeed, while the whole universe of
microbial peptides can amount to more than 1000 different molecules, the TLR ligands
are a reduced set amounting to > 20 elements, which can be sensed by a set of ~10
TLRs. Each TLR must thus show a degree of degeneracy [34]. Signals detected by
TLRs are then mediated by very few (four) adaptor molecules, primary (two) and
Figure 3 Example of a technological structure organized as a bow tie. Aerial view of the Bologna
freight marshalling yard, clearly showing a structure analogous to a bow tie. Wagons arrive from a variety
of sources (left bow); to facilitate control and sorting out operations, they are driven through a narrowing:
few rails under strict supervision to ensure the maximal capability for control and decision-making; from
here they are dispatched to a plethora of new destinations (right bow). Again, the narrowing (the ‘core’
surveillance station) allows economical and effective regulation to be taken and exercised on a variety of
inputs (train provenances) and to yield a quantity of outputs (new destinations). Inspired by Needham
[122], p. 170, Figure forty five. Image from Google Maps.
Tieri et al. Theoretical Biology and Medical Modelling 2010, 7:32
http://www.tbiomed.com/content/7/1/32
Page 7 of 16
secondary (≈ 10) kinases, that are able to pass the signal to transcription factors (NF-
B and STAT1) which in turn can activate a large number of genes (> 500) and initi-
ate subsequent events (> 1000) [32].
In a further analysis [13], a comprehensive TLR signalling map shows that the whole
network can be roughly divided into four possible subsystems, the most important
being the main system with MyD88-IRAK4-IRAK1-TRAF6 hub proteins as a bow tie
core process. This core is able to mediate the activation of NF-B and the mitogen-
activated protein kinase (MAPK) cascade, which in turn activates many target genes.
Interestingly, recent network topology studies highlighted that the dynamics of MAPK
signalling is ruled by the pervasive presence in the cascade network of bifan motifs
[46], which occur when signals from two upstream molecules integrate to modulate
the activity of two downstream molecules. Bifan motifs are also overrepresented in
transcriptional networks [47].
Unlike metabolic networks, signalling networks show a bow tie core composed by
very few key molecules such as cyclic adenosine monophosphate (cAMP) and Ca2+ in
G-protein coupled receptor signalling [48], and MyD88 for TLRs [13]. Such signalling
networks may thus be prone to fragilities owing to the perturbation of such molecules.
Indeed, knockouts of such hub proteins in mice are fatal to the organism because they
impair the correct signalling of the innate immune system leading to severe failures to
detect pathogen-associated molecular signatures [6].
TCR, degeneracy, bow tie and noise
Like the TLRs, the TCR system functioning resembles a bow tie, as already described
by Kitano and Oda [6]. This signalling system senses and controls the critical flux of
information from outside to inside the T cell using few components and protocols [6].
Thanks to its characteristic degeneracy, the TCR is able to discriminate among a larger
number of ligands than any other known receptor systems (the fan in; [38]). To man-
age the complexity of inbound signals, the TCR molecular structure works like proto-
cols for ligand recognition and signal transduction. These protocols operate at the
level of the single receptor as well as at the emerging level that derives from integra-
tion of multiple signals by the collective of interacting cells. The signal originating
from ligand binding is a function of the affinity of the TCR for peptide-MHC com-
plexes and of their concentration [49]. The TCR machinery is thus able to decompose
and translate it into TCR signal strength, which finally determines the various cell
functional outcomes. This condition determines a continuum of inputs to the TCR
("TCR signalosome”) and is atypical among cell receptors, requiring elaborate compu-
tational capabilities by the TCR system [49].
There are other interesting features in the TCR architecture: the TCR machinery
shows a characteristic modular design in terms of functional and spatial separation of
its ligand-binding modules lacking intrinsic signalling capability [50]. Moreover, owing
to exposure to continuous, weak TCR-ligand interactions, the TCR works under ‘noisy’
conditions. In this respect, there is now mounting evidence that this noise has a func-
tional role in terms of receptor sensitivity: non-activating TCR-ligand interactions may
modulate the sensitivity of T cells to antigens [51].
All these advanced characteristics (diversification of inputs, protocols for complex
signal integration/transmission, modular design, functional noise) can be framed and
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fully understood only through the simultaneous consideration of more than one
powerful yet single concept such as that of degeneracy. This integrative approach is
not only able to explain a complex set of features, it also opens unanswered questions
regarding the composition of the TCR bow tie core, the impact of TCR bow tie core
proteins on global TCR dynamics, and the comprehension of TCR signal processing
protocols.
Proteasome: packing principles into a single chamber
Other crucial IS structures that show bow tie architecture are proteasomes, organelles
constituted by large protein complexes with the main function of degrading unnecessary
or damaged proteins by proteolysis. They are highly polyspecific enzymes because they
are able to process a wide range of cellular proteins. Through the available proteasome
machinery, a single cell is able to collect 2 × 106 proteins per minute, which are
degraded by the physical chamber formed by the complex of 14 distinct protein subu-
nits, working under well-specified protocols for protein degradation. The degradation
core then fans out ~108 oligopeptides per minute [52]. Several isoforms of proteasomes
with slightly different specificities are present, often at the same time, in a single cell
[53,54]. The ratios among different proteasome isoforms could be modulated by various
factors and are proposed to play a role in several diseases [55-59]. One of these isoforms,
known as the immunoproteasome, enhances the generation of specific antigenic epi-
topes that are presented to the MHC class I molecules on antigen-presenting cells and
recognized by CD8+ T cells. In an informational sense, the proteasome can be consid-
ered as a signal processing system: it processes a protein, cleaving it into peptides, which
may be further cleaved in single amino acids by aminopeptidases or transported into the
ER and exposed as epitopes on MHC class I complexes [60]. In the latter case, protea-
somes ‘extract’ more epitopes from the single amino acidic sequence of the original pro-
tein (the antigen), which could activate several CD8+ T cell clones (one-to-many).
Intriguingly, two different groups have discovered in recent years that the proteasome-
mediated “sequence extraction” from a given antigen could result from a splicing of two
non-contiguous sequences [61]. Very recent investigations suggest that this phenom-
enon, called proteasome splicing, is not a rare event and therefore represents an example
of further pluripotentiality because it provides more epitopes from a given antigen than
canonically supposed [62]. Therefore, within proteasome-mediated MHC class I antigen
presentation, two antithetic principles could be recapitulated: the pluripotentiality of
proteasome-mediated epitope production (pluripotentiality further expanded by protea-
somal splicing), followed by the degeneracy of CD8+ T cell activation mediated by the
MHC class I - epitope signal. Indeed, epitopes extracted from a given antigen have dif-
ferent amino acid sequences and could lead to the activation of different CD8+ T cells;
these latter then recognize the single antigen and, as a consequence, the correlated
pathogen. This concurrence of pluripotentiality and degeneracy is probably the most
important attribute of the cell-mediated immune response and it allows the IS, for
example, to struggle against the high mutability of virus.
Proteasome, bow tie and noise
Certainly, as signal processing system, the proteasome operates under the action of a
fundamental biological condition: noise. As stochastic fluctuations in the quantitative
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parameters that rule the functioning of living systems at diverse levels [63], noise is
present in each stage of proteasome function. There are two aspects of signal proces-
sing under noisy conditions. First, the system should be robust against noise and fluc-
tuations and be able to respond to the noisy signal. Second, the system, owing to
evolutionary adaptation, may have evolved to use noise for constructive purposes. We
believe that the robustness of operation of the proteasome in performing sequence-
specific protein cleavage is provided by the digital nature of the amino acid sequence.
This excludes the influence of noise in the sequence; however, noise is still present in
the fluctuating quantity of protein copies and, as thermodynamic noise in the course
of protein binding to the proteasome, in protein translocation and binding to the clea-
vage terminal. Could this noise counter-intuitively play a constructive role and not cor-
rupt the quality of signal processing? In statistical physics, four basic noise-induced
phenomena are known, each leading to noise-induced ordering of a non-equilibrium
system. These basic effects are stochastic resonance [64], noise-induced transport [65],
coherence resonance [66], and noise-induced phase transitions [67]. It is important to
note that noise-induced phenomena have been experimentally detected at all levels of
biological functionality, e.g. in plankton detection by paddle fish [68], in the human
balance system [69], in the retrieval processes of the human memory [70], and in
human brain waves [71]. Even more importantly, it has been shown that biological sys-
tems may evolutionarily adapt so that the intensity of noise is optimal for the mechan-
isms behind noise-induced phenomena. How can noise potentially play a constructive
role in proteasome function? Some authors have addressed the question whether pro-
tein translocation inside the proteasome chamber can be driven by fluctuations and
have derived a toy-model to show that translocation is probably based on a fluctua-
tion-driven transport mechanism [72]. At the moment, there is no experimental verifi-
cation of this hypothesis; however, we expect that this could be obtained if the
translocation function were reconstructed from the experimental data using the
method suggested by Goldobin et al. [73]. On the other hand, considering the protea-
some as a signal detection system, it would be logical to assume that the detection is
evolutionarily optimized to use the principle of stochastic resonance. Stochastic reso-
nance has manifested itself as a generic phenomenon widely found in biological sys-
tems. One more argument in favour of this hypothesis is that proteins dealing with
responses to external changes are much more noisy in terms of their concentration, as
for example those involved in intracellular protein synthesis. This follows from the
proteomic analysis and reconstruction of biological noise [63]. Signal detection in the
form of epitope extraction occurs in much more noisy conditions such as simple pro-
tein digestion, so it was evolutionary profitable for proteasome function to be opti-
mized to this genetic noise.
Conclusion and perspectives
The increasing awareness that biological complexity is not satisfactorily described by
widely-used but single and isolated concepts drives the quest for integrative theoretical
scaffolds to achieve a more comprehensive, systemic understanding of biological sys-
tems, including the IS. It is crucial, in this perspective, to clarify the structure-function
relationships of biological systems at all levels of their organization, and in the first
instance to have a clearer picture of the architectures that sustain their dynamics.
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In this essay we have shown that the operational functions of basic structures of the
IS such as the TLR, the TCR, and the proteasome obey global principles, and are orga-
nized according to general architectures and structures that work in a strictly and dee-
ply intertwined manner, such as those of network, degeneracy and bow tie. These are
the result of evolutionary processes of optimization between economy of resources and
capability of reaction. Indeed, from the viewpoint of ecological immunology, it is
assumed that immunological defences must be minimized in terms of cost, i.e. energy
expenditure [74,75]. We recently discussed the hypothesis that the bow tie architecture
might be suitable for describing the variety of immune-neuroendocrine inputs that
continuously target cells and organs while, at the same time, fulfilling the basic
requirement of minimizing the cost of immune-neuroendocrine responses [76].
On the other hand, emerging evidence about genetic networks links up wiring patterns
of interactions (architecture) with their behaviour in the presence of biological noise,
suggesting that noise has a role directly encoded in gene circuit architecture [77].
Recent proposals in the direction of this integrative approach envisage the complex
architecture of metabolic pathways as a network of modular and nested bow ties [41].
The advantage of this approach is that the elements of the network are no longer con-
sidered as simple entities, but rather as functional modular units, interacting on differ-
ent functional layers and characterized by a sophisticated level of complexity. The
drawback of this approach is the intrinsic difficulty of a rigorous (mathematical) tract-
ability, which is a urgent challenge in systems biology [78]. Similarly, a better under-
standing of proteasome function will be able to overcome the limits of available
models [79], which are still unable to account for the full universe of the generated
peptides and its dynamics.
In general, we surmise that a systematic and integrative use of concepts such as
degeneracy and bow tie architecture, in combination with and within the framework of
a network perspective [3], should be very useful not only for elucidating the general
rules governing complex biological systems but also for identifying their hidden and
specific fragilities and weak points, which represent the start of pathologies, extending
previous suggestions from pioneer scientists [5,6,13].
Appendix. History and pervasiveness of degeneracy
The origin: a physico-mathematical notion
The first use of the term degeneracy in the scientific literature can be traced to the
early days of quantum theory when it came to define different stationary states (with
different wave-functions) corresponding to the same energy level [80-82]. During the
heyday of quantum theory in the 1930s and 1940s, different nascent disciplines began
to borrow concepts from physics in an attempt to acquire scientific prestige: Degener-
acy was chosen specifically by biology, biochemistry and communication engineering
[83,84]. In such new contexts, the notion of degeneracy abandoned its original phy-
sico-chemical meaning and came to define any class of objects in which different ele-
ments (i.e. inputs) could perform the same function (i.e. output).
Biological acceptance: the genetic code is degenerate
The first entry of degeneracy into the biological field was due to Crick in 1955 [85].
Inspired by Gamow’s reflections on the relationship between DNA and proteins [86],
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Crick dedicated a paper on genetic code degeneracy, suggesting that its role was essen-
tial for explaining how different codons could express one amino acid. Ensuing theore-
tical analyses stressed the importance of degeneracy by considering Crick’s “central
dogma” of the unidirectional flow of genetic information (from DNA to RNA to pro-
tein [87-89]), “a purely mathematical property of the degeneracy of the genetic code”
[90].
Immunological and neural speculations
Although molecular biology favoured the entry of degeneracy into the biological field,
immunology has to be recognized as the discipline that gave it a fundamental and
wide-ranging explanatory role. In 1959 Talmage opposed the long-lasting “one-antigen,
one-antibody” model by introducing the idea that different globulins would cross-react
with a single antigen [91], a concept Eisen named degeneracy ten years later [92].
Along these lines of research, Edelman further developed the concept of degeneracy by
suggesting two different operative dimensions: (i) at the level of the antibody-gene
repertoire, degeneracy was the underlying mechanism used by the IS to achieve both
specificity (i.e., self-nonself discrimination, tolerance, booster effect) and universality
(i.e., generation of diversity) in antigen recognition; (ii) at the organismal level, and
then presuming an analogy between somatic and natural selection mechanisms, degen-
eracy was also a general evolutionary strategy to produce adaptability to unforeseen
environments [93,94].
In his subsequent shift to neurobiology, Edelman explained the synaptic function of
the nervous system as similar to the mechanism of cellular differentiation and selection
of the IS, a new context in which degeneracy was used to describe two structurally dif-
ferent neural networks equivalent in their abilities to respond to a certain signal
[95,96]. The formation of a repertoire of degenerate neuronal groups could then
explain the brain as a modular system, affording it an evolutionary robustness to
damage via the substitution of the damaged structure by others performing the same
function [97,98].
The pervasive multidisciplinarity of degeneracy
By extending the theory of neuronal group selection to embrace computer modelling,
Edelman subsequently used degeneracy to design selective network-based automata to
improve their learning and recognition ability [99,100]. In considering degeneracy to
be a prominent property of evolution itself - being both a prerequisite for, and an
inevitable outcome of, natural selection - Edelman attempted to apply it to a list of 22
phenomena over all levels of biological organization, ranging from the genetic code,
through molecular and functional brain architectures, to human communication [4].
To underpin such a large-scale program, he also offered a more coherent formalization
and provided a mathematical treatment of degeneracy that turned out to be strictly
related to a measure of biological complexity [101,102]. Owing to the inherent stereo-
chemical nature of both antigen-antibody interactions and synaptic networks, Edelman
has the theoretical credit of having integrated the classical mathematical framework of
degeneracy with a new topobiological interpretation that knits together the structural
and functional dimensions of biological organisms.
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Recent scientific literature, especially in the immunological and neurological fields,
has paid increasing attention to degeneracy as an organizing principle for describing
the properties and dynamics of complex biological networks. As for immunology,
works worth mentioning analyze degeneracy as: a historical event in the context of
antigen-antibody reaction [103]; the “Yin and Yang of the immune system” for its pivo-
tal role in T and B cell functions [104]; an argument in the ongoing debate to discredit
self-nonself theory [105]; a tool to design vaccines for the treatment of infectious dis-
eases ([106,107] and cancer [108]; an age-associated parameter of T-cell reactivity
[109]; a main property of the IS cognate to, yet different from, that of cross-reactivity
[103,110], molecular mimicry [111,112], polyspecificity [38,113], promiscuity
[107,110,114], pluripotentiality [25] and specificity [78,115]. Degeneracy is also applied
in neuroscience to explain neuroanatomical functional architecture [24-26], in compu-
tational biology to improve PCR performance [116,117], in evolutionary biology as a
key parameter for evaluating complexity [101,102,118], species evolutionary distance
[119] and evolution of morphological novelties [120], as well as in psychology as a
mechanism underling language acquisition [121].
We are aware that the historical development of degeneracy dealt with concepts (e.g.
modularity and robustness) and biological levels (cellular networks, distributed systems,
evolutionary dimension) that are typically involved in bow tie models. Both notions are
indeed based on a promising many-to-one structure-function relationship (Figure 2),
which seems to be a ubiquitous architectural constraint exploited by evolution to
afford efficiency (modular-base structures), robustness (non-catastrophic response to
variations) and evolvability in highly complex networks.
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